VentriPoint Diagnostics Ltd VPTDF
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.06–0.14
- Bid/Ask
- $0.05 / $0.06
- Shares Outstanding
- 192.88M
- Market Cap
- $11.47M
- Volume/Avg
- 247,975 / 120,408
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 101.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.ventripoint.com
Valuation
|
Metric
|
VPTDF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 101.87 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VPTDF
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.12 |
Interest Coverage | −3.27 |
Quick Ratio
VPTDF
Profitability
|
Metric
|
VPTDF
|
|---|---|
Return on Assets (Normalized) | −463.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VPTDF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|#CvJ#$^ | LOCK|^m%K | $178B | |||
| Medtronic PLC
MDT
| LOCK|$JRbp< | LOCK|BJbcH | $119B | |||
| Stryker Corp
SYK
| LOCK|RkxdX<J | LOCK|ZDB | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|>@&Nwh | LOCK|P!>!G | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|hv^yXp? | LOCK|JF^> | $49B | |||
| DexCom Inc
DXCM
| LOCK|zp!?HK>Y | LOCK|>Nnl | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|vc#TrZ@ | LOCK|!V? | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Y<l | LOCK|PH? | $24B | |||
| Steris PLC
STE
| LOCK|BbBF$g | LOCK|#g>& | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|GBQcxpLf | LOCK|<b< | $18B |
United States